1. Home
  2. SNPX vs FMTO Comparison

SNPX vs FMTO Comparison

Compare SNPX & FMTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNPX
  • FMTO
  • Stock Information
  • Founded
  • SNPX 2012
  • FMTO 2000
  • Country
  • SNPX United States
  • FMTO Israel
  • Employees
  • SNPX N/A
  • FMTO N/A
  • Industry
  • SNPX Medicinal Chemicals and Botanical Products
  • FMTO
  • Sector
  • SNPX Health Care
  • FMTO
  • Exchange
  • SNPX Nasdaq
  • FMTO NYSE
  • Market Cap
  • SNPX 3.1M
  • FMTO 3.0M
  • IPO Year
  • SNPX N/A
  • FMTO N/A
  • Fundamental
  • Price
  • SNPX $2.41
  • FMTO $4.60
  • Analyst Decision
  • SNPX Strong Buy
  • FMTO
  • Analyst Count
  • SNPX 1
  • FMTO 0
  • Target Price
  • SNPX $14.00
  • FMTO N/A
  • AVG Volume (30 Days)
  • SNPX 19.8K
  • FMTO 35.5K
  • Earning Date
  • SNPX 05-15-2025
  • FMTO 08-06-2025
  • Dividend Yield
  • SNPX N/A
  • FMTO N/A
  • EPS Growth
  • SNPX N/A
  • FMTO N/A
  • EPS
  • SNPX N/A
  • FMTO N/A
  • Revenue
  • SNPX N/A
  • FMTO $620,978.00
  • Revenue This Year
  • SNPX N/A
  • FMTO N/A
  • Revenue Next Year
  • SNPX N/A
  • FMTO N/A
  • P/E Ratio
  • SNPX N/A
  • FMTO N/A
  • Revenue Growth
  • SNPX N/A
  • FMTO N/A
  • 52 Week Low
  • SNPX $1.84
  • FMTO $3.85
  • 52 Week High
  • SNPX $5.05
  • FMTO $6,927.50
  • Technical
  • Relative Strength Index (RSI)
  • SNPX 49.39
  • FMTO N/A
  • Support Level
  • SNPX $2.51
  • FMTO N/A
  • Resistance Level
  • SNPX $2.76
  • FMTO N/A
  • Average True Range (ATR)
  • SNPX 0.18
  • FMTO 0.00
  • MACD
  • SNPX 0.03
  • FMTO 0.00
  • Stochastic Oscillator
  • SNPX 45.10
  • FMTO 0.00

About SNPX Synaptogenix Inc.

Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

About FMTO FEMTO TECHNOLOGIES INC

Femto Technologies Inc is an integrated software company. It owns and markets Benefit CRM, a proprietary customer relationship management CRM software product enabling small and medium sized businesses to optimize their day to day business activities such as sales management, personnel management, marketing, call center activities, and asset management.

Share on Social Networks: